# EDGAR Filing Document

**Accession Number:** 0002068669
**File Stem:** 0001477932-25-004324
**Filing Date:** 2025-6
**Character Count:** 5180
**Document Hash:** df4d651f677d5f9d6e6ef21ede289d12
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-004324.hdr.sgml**: 20250603

**ACCESSION NUMBER**: 0001477932-25-004324

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250523

**FILED AS OF DATE**: 20250603

**DATE AS OF CHANGE**: 20250603

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Rudick Brian Benjamin
- **CENTRAL INDEX KEY:** 0002068669

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40535
- **FILM NUMBER:** 251017077

**MAIL ADDRESS:**
- **STREET 1:** 400 S. US HIGHWAY 1 APT 401
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33477
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UPEXI, INC.
- **CENTRAL INDEX KEY:** 0001775194
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 833378978
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 3030 ROCKY POINT DRIVE
- **STREET 2:** SUITE 420
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 701-353-5425

**MAIL ADDRESS:**
- **STREET 1:** 3030 ROCKY POINT DRIVE
- **STREET 2:** SUITE 420
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GROVE, INC.
- **DATE OF NAME CHANGE:** 20190429

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Rudick Brian Benjamin<br><sub>(Last) (First) (Middle)</sub><br>400 S. US HIGHWAY 1 APT 401<br><sub>(Street)</sub><br>JUPITER, FL 33477<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>UPEXI, INC. [ UPXI ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-05-23-05:00 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_CSO_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 438597 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Warrant to purchase  Common shares | 2025-05-29-05:00 | 2032-04-24-05:00 | Common Stock | 21930 | $2.28 | D |  |
| Warrant to purchase  Common shares | 2025-05-29-05:00 | 2032-04-24-05:00 | Common Stock | 10965 | $3.42 | D |  |
| Warrant to purchase  Common shares | 2025-05-29-05:00 | 2032-04-24-05:00 | Common Stock | 10965 | $4.56 | D |  |
| Warrant to purchase  Common shares | 2025-05-29-05:00 | 2032-04-24-05:00 | Common Stock | 10965 | $5.70 | D |  |
| Warrant to purchase Common shares | 2025-11-29-05:00 | 2032-04-24-05:00 | Common Stock | 27412 | <sup>(1)</sup> | D |  |
| Warrant to purchase Common shares | 2026-05-29-05:00 | 2032-04-24-05:00 | Common Stock | 27412 | <sup>(2)</sup> | D |  |

---

### Footnotes:

(1) Warrant to purchase 10,965 ex price $2.28, 5,483 ex price $3.42, 5482 ex price $4.56 and 5,482 ex price $5.70

(2) Warrant to purchase 10,965 ex price $2.28, 5,483 ex price $3.42, 5482 ex price $4.56 and 5,482 ex price $5.70

**Signature:** /s/ Brian Benjamin Rudick  
**Date:** 2025-06-02-05:00

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**